MATX vs MRCY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MATX exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet stability. While the current price ($173.35) sits slightly above the Graham Number ($167.93), it remains significantly undervalued relative to its growth-based intrinsic value of $407.4. Despite a recent decline in revenue growth (-4.30%), the company has maintained strong earnings growth (21.20%) and a consistent track record of beating EPS estimates. The primary headwinds are bearish insider sentiment and a critical regulatory dependency on the Jones Act.
Mercury Systems presents a contradictory profile: a stable financial foundation (Piotroski F-Score 5/9) and strong liquidity contrasted by negative profitability and aggressive insider selling. While the balance sheet is healthy with a low Debt/Equity ratio of 0.47 and a strong Current Ratio of 2.96, the valuation is stretched with a Forward P/E of 56.09 and negative profit margins. The stark divergence between bullish analyst targets ($96.88) and bearish insider activity ($150M in sales) suggests significant internal skepticism despite external optimism.
Compare Another Pair
Related Comparisons
MATX vs MRCY: Head-to-Head Comparison
This page compares Matson, Inc. (MATX) and Mercury Systems, Inc. (MRCY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.